Call me thick, but this makes no sense. None. Bupkis. Zilch. Zero. PFE stock has beaten analyst expectations for three consecutive quarters. What's more, Morgan Stanley projects that Pfizer will pocket $19 billion in Covid-19 vaccine revenue in 2021. That's on top of the estimated $975 million it realized in 2020 and not factoring in what it will make from Covid-19 shots in 2022 and 2023.